Brief Index of Sexual Functioning for Women

1. Abstract

The Brief Index of Sexual Functioning for Women (BISF-W) is a multidimensional, 22-item self-report psychometric instrument designed to assess female sexual functioning, satisfaction, and dysfunction across both clinical practice and research settings. Developed by Raymond C. Rosen, Jennifer F. Taylor, and Sandra R. Leiblum at the Robert Wood Johnson Medical School, the instrument was formulated to address a notable psychometric gap: the absence of a standardized, brief, yet comprehensive self-report measure evaluating the full spectrum of female sexual response. Drawing conceptual inspiration from the male-focused Brief Sexual Function Questionnaire (BSFQ; Reynolds et al., 1988), the BISF-W captures both behavioral frequencies and qualitative subjective appraisals over a 30-day recall period.

The scale systematically operationalizes seven core dimensions: Thought/Desire, Arousal, Frequency of Sexual Activity, Receptivity/Initiation, Pleasure/Orgasm, Relationship Satisfaction, and Sexual Problems/Anxiety/Pain, with supplemental single-item indicators capturing body image, partner availability, and sexual orientation. Principal components analyses initially delineated three macro-level factors designated as Sexual Desire, Sexual Activity, and Sexual Satisfaction, while subsequent psychometric refinements supported a nuanced seven-factor composite scoring framework. Internal consistency coefficients vary across dimensions, with Cronbach’s alpha values ranging from .39 to .83 in early validation studies and reaching higher reliability in updated composite scoring paradigms (.70 to .88). Test-retest reliability across a one-month interval demonstrates stability, yielding Pearson correlation coefficients between .68 and .78. Concurrent validity is well substantiated through moderate to high correlations with the Derogatis Sexual Functioning Inventory (DSFI; r = .59 to .69), whereas discriminant validity is supported by non-significant associations with the Marlowe-Crowne Social Desirability Scale. This article provides an exhaustive psychometric examination of the BISF-W, outlining its developmental rationale, theoretical underpinnings, structural properties, and ongoing clinical utility.

2. Keywords

Brief Index of Sexual Functioning for Women, BISF-W, female sexual dysfunction, sexual desire, sexual arousal, orgasm, female sexual response, psychometrics, sexual satisfaction, sexual pain, validation, self-report inventory.

3. Authors

The Brief Index of Sexual Functioning for Women was constructed and validated by a distinguished team of clinical psychologists and medical researchers affiliated with the Department of Psychiatry at the University of Medicine and Dentistry of New Jersey (UMDNJ) – Robert Wood Johnson Medical School (Piscataway and New Brunswick, NJ):

• Raymond C. Rosen, Ph.D.: Professor of Psychiatry and Medicine, Robert Wood Johnson Medical School; later Chief Scientist at the New England Research Institutes (NERI), Watertown, MA. Renowned international authority on sexual medicine, male and female sexual psychometrics, and principal architect of both the BISF-W and the Female Sexual Function Index (FSFI). E-mail correspondence was historically directed to: [email protected].
• Jennifer F. Taylor, Ph.D.: Clinical researcher and psychophysiologist, Department of Psychiatry, Robert Wood Johnson Medical School, whose work focused on female sexual health assessment, gynecological survey methodologies, and behavioral medicine.
• Sandra R. Leiblum, Ph.D. (1943–2010): Professor of Psychiatry and Obstetrics/Gynecology, Director of the Center for Sexual and Relationship Health at UMDNJ – Robert Wood Johnson Medical School. A pioneering sexologist, former president of the International Academy of Sex Research (IASR) and the Society for Sex Therapy and Research (SSTAR), and internationally recognized for her seminal contributions to understanding female sexual desire, persistent genital arousal disorder (PGAD), and psychological aspects of reproductive medicine.

4. Purpose

During the late 1980s and early 1990s, sex research and clinical trials confronted a glaring methodological asymmetry. While validated, brief screening tools such as the Brief Sexual Function Questionnaire (BSFQ; Reynolds et al., 1988) and the International Index of Erectile Function (IIEF) were established or rapidly emerging for men, equivalent standardized instruments for women remained severely limited. Existing measures were either excessively long and burdensome—such as the 261-item Derogatis Sexual Functioning Inventory (DSFI)—rendering them impractical for clinical trials or community epidemiological research, or they were overly narrow, focusing exclusively on coital frequency or isolated physical complaints.

The primary purpose of the BISF-W was to establish a brief, standardized, psychometrically rigorous, self-report inventory that captures the multidimensional nature of female sexual response. The instrument was intentionally engineered to serve several pivotal clinical and empirical functions:

• Comprehensive Clinical Screening: To provide gynecologists, psychiatrists, primary care physicians, and sex therapists with an efficient tool (requiring 10 to 15 minutes) to identify specific areas of female sexual complaint, including hypoactive sexual desire, arousal failure, orgasmic difficulty, dyspareunia, and sexual anxiety.
• Outcome Measurement in Clinical Trials: To establish a sensitive, standardized baseline and post-treatment outcome measure for evaluating pharmacological, psychological, and hormonal interventions (such as postmenopausal hormone replacement therapy, sildenafil trials in women, or psychotherapeutic protocols for sexual dysfunction).
• Epidemiological and Survey Utility: To permit large-scale population-based research regarding the prevalence, correlates, and demographic distribution of female sexual functioning without inducing high rates of respondent fatigue or missing data.
• Theoretical Integration of Affective and Partner Factors: Unlike early masculine models that prioritized genital erection and ejaculation frequency, the BISF-W was designed to reflect the contextual reality of female sexuality, integrating partner initiation, dyadic satisfaction, sexual communication, and subjective body image.

5. Psychological Construct

The BISF-W operationalizes female sexual functioning as an interactive, biopsychosocial phenomenon encompassing psychological, behavioral, interpersonal, and physiological domains. Rather than viewing sexual response as an involuntary physiological reflex, the construct assumes that female sexual health is mediated by affective states, cognitive appraisals, dyadic dynamics, and bodily comfort. The instrument measures seven distinct dimensions alongside discrete situational variables:

1. Sexual Thought and Desire (Items 1, 2, 3)

This construct assesses the cognitive and motivational precursors to sexual behavior. It measures the frequency of sexual ideation, erotic daydreams, night dreams with sexual content, and the qualitative intensity (craving or subjective longing) of sexual desire over the preceding 30 days. Deficits in this dimension reflect Hypoactive Sexual Desire Disorder (HSDD) as characterized by traditional psychiatric diagnostic criteria.

2. Arousal and Physiological Lubrication (Items 4, 5, 6, 7)

This subscale captures the subjective and somatic aspects of sexual excitement. It assesses the frequency with which a woman becomes mentally “turned on” during erotic encounters, the perception of genital vasocongestion (vaginal lubrication or “becoming wet”), the presence and clarity of physical sensations in the pelvic region, and the subjective difficulty encountered in attaining adequate arousal. This dimension corresponds directly to Female Sexual Arousal Disorder.

3. Frequency of Sexual Activity (Items 8, 9, 10)

A purely behavioral dimension quantifying the objective occurrence of varied sexual practices over the past month. Rather than limiting activity to penile-vaginal intercourse, it independently evaluates partner-related sexual interactions (including intercourse, oral sex, and mutual manual stimulation), solitary masturbation, and affectionate erotic behaviors such as prolonged foreplay and petting.

4. Receptivity and Initiation (Items 11, 12, 13)

Reflecting the interpersonal and assertiveness dimensions of female sexuality, this construct captures proceptive and receptive behavioral patterns. It gauges how frequently the woman initiates sexual contact, how willingly and enthusiastically she responds when her partner initiates, and the frequency with which she actively avoids or rejects partner advances. This acknowledges that low spontaneous initiation does not necessarily imply low sexual responsiveness or an inability to enjoy intimacy.

5. Pleasure and Orgasm (Items 14, 15, 16, 17)

This dimension operationalizes both the physiological climax and the hedonic tone of sexual activity. It assesses orgasmic frequency during partnered interactions, the subjective intensity and pleasure derived from orgasms, the level of difficulty experienced in achieving climax, and the global hedonic pleasure experienced during sexual encounters throughout the preceding month. This domain aids in the differential diagnosis of Female Orgasmic Disorder.

6. Relationship Satisfaction (Items 18, 19)

A dyadic appraisal construct that assesses the respondent’s cognitive satisfaction with the frequency of shared sexual encounters and her overall satisfaction with the sexual relationship. It recognizes that subjective satisfaction can remain high even when physiological functioning or frequency is modest, and vice versa.

7. Sexual Problems, Anxiety, and Pain (Items 20, 21, 22)

This construct evaluates distress and physical discomfort associated with sexual intimacy. It screens for genital pain during or after penetration (dyspareunia or vaginismus/genito-pelvic pain penetration disorder), the degree to which pain impairs the sexual experience, and the presence of cognitive-affective tension, performance anxiety, or autonomic nervousness during sexual encounters.

Single-Item Indicators

Item 16 in the original factor structure evaluates body image and physical self-esteem, assessing how self-conscious or comfortable the woman feels about her body during intimacy. Items 1, 2, 21, and 22 in demographic modules record partner status, partner health, and sexual orientation (attraction and behavior), ensuring context-sensitive interpretation.

6. Theoretical Framework

The construction of the BISF-W is grounded in the evolution of modern sexological theory, bridging the classic physiological phase models of the 20th century with contemporary cognitive-affective and biopsychosocial frameworks.

The Triphasic Model of Sexual Response

Historically, William H. Masters and Virginia E. Johnson (1966) proposed a linear physiological model consisting of four stages: Excitement, Plateau, Orgasm, and Resolution. While groundbreaking, this framework treated sexual response almost exclusively as a sequence of vasocongestive and myotonic genital reflexes, largely omitting cognitive, motivational, and emotional determinants.

To remedy these deficits, psychotherapist and psychiatrist Helen Singer Kaplan (1974, 1979) introduced the Triphasic Model of Sexual Response, which reorganized human sexual expression into three interrelated but neurophysiologically distinct phases: Desire, Arousal, and Orgasm. Kaplan demonstrated that each phase is governed by distinct neurochemical systems and autonomic divisions: desire by dopaminergic and neuroendocrine circuits in the limbic system; arousal by parasympathetic vasocongestion of pelvic vasculature; and orgasm by sympathetic spinal reflexes.

The BISF-W explicitly adopted Kaplan’s triphasic distinction as its structural foundation, dedicating specific item clusters to subjective desire, physiological arousal/lubrication, and orgasmic functioning. This alignment facilitated direct mapping onto the psychiatric diagnostic criteria of the DSM-III-R and DSM-IV.

Anticipation of the Circular and Responsive Models

During the developmental phase of the BISF-W, clinical sexologists—prominently including co-author Sandra R. Leiblum—recognized that female sexual desire often operates differently from male desire. Whereas healthy males frequently report spontaneous, internally generated sexual hunger, women in long-term relationships often experience sexual desire as responsive—triggered by intimacy, emotional connection, and non-genital foreplay.

This conceptualization later culminated in Rosemary Basson’s (2000) Circular Model of Female Sexual Response. The BISF-W anticipated this paradigm shift by incorporating items measuring receptivity to partner initiation, affective anxiety, body image, and relationship satisfaction alongside spontaneous thoughts and fantasies. By disaggregating solitary drive (fantasy, masturbation) from dyadic receptivity, the scale accounts for modern circular and biopsychosocial paradigms of female sexual health.

7. Validity

The psychometric validity of the BISF-W has been confirmed across clinical cohorts, gynecological outpatient settings, and community-dwelling epidemiological samples.

Convergent Validity

Convergent validity was evaluated by comparing BISF-W factor scores with corresponding scales of the Derogatis Sexual Functioning Inventory (DSFI), an established 261-item multidimensional test. In validation cohorts (Rosen et al., 1993), correlations between the BISF-W factors and relevant DSFI subscales were consistently positive and statistically significant (p < .001), exhibiting moderate to strong coefficients:

• Sexual Desire: Correlated significantly with the DSFI Sexual Drive subscale (r = .64).
• Sexual Activity: Correlated robustly with the DSFI Sexual Experience and Behavior subscales (r = .69).
• Sexual Satisfaction: Demonstrated solid concordance with the DSFI Sexual Satisfaction index (r = .59).
• Body Image: Item 16 of the BISF-W, dedicated to physical body esteem, exhibited a strong positive correlation with the DSFI Body Image Scale (r = .62, p < .001).

Discriminant and Criterion Validity

To establish that the inventory reflects genuine sexual functioning rather than response styles or social desirability bias, the BISF-W was administered alongside the Marlowe-Crowne Social Desirability Scale (Crowne & Marlowe, 1964). No significant correlations were observed between any of the BISF-W factor scores and the Marlowe-Crowne scale, confirming that self-reported sexual behavior, satisfaction, and dysfunction are free from confounding evaluative dependence or defensive distortion.

Known-groups validity has been demonstrated across diverse demographic and clinical populations. In an outpatient gynecological clinic survey of 329 women (Rosen, Taylor, Leiblum, & Bachmann, 1993), the BISF-W discriminated reliably between premenopausal and postmenopausal women, detecting expected physiological reductions in lubrication and frequency while delineating variations across relationship status and age cohorts. Subsequent studies (e.g., Mazer et al., 2000) demonstrated that the BISF-W successfully differentiates between women diagnosed with female sexual dysfunction (FSD) and matched healthy controls, showing large effect sizes across desire, arousal, and pleasure domains.

8. Reliability

The reliability of the BISF-W has been scrutinized via internal consistency analyses and temporal stability assessments across diverse patient and community samples.

Internal Consistency

In the primary psychometric validation study involving 269 women aged 20 to 73 years (Rosen et al., 1993), internal consistency was determined using Cronbach’s alpha for the principal component factor scales:

• Factor 2 (Sexual Activity): Demonstrated robust internal consistency, with an alpha coefficient of α = .83, reflecting high homogeneity among behavioral participation items.
• Factor 3 (Sexual Satisfaction): Displayed acceptable internal consistency, with an alpha coefficient of α = .76.
• Factor 1 (Sexual Desire): Exhibited an alpha of α = .39 in the initial 3-factor principal components model. As noted by the authors, this low coefficient was an artifact of split factor loadings, wherein items tapping cognitive desire also loaded onto general behavioral engagement and relational receptivity.

When the questionnaire is scored using the refined seven-dimension conceptual framework (as operationalized by Mazer, Leiblum, & Rosen, 2000), internal consistency improves substantially across individual domains, with subscale alphas routinely falling between .70 and .88, satisfying psychometric standards for group-level clinical trials.

Test-Retest Stability

Temporal stability was evaluated in a subcohort of women reassessed over a 1-month (30-day) interval under stable clinical conditions. Pearson product-moment correlations between baseline and 1-month scores confirmed good stability across all primary domains:

• Sexual Desire Factor: r = .71 (p < .001)
• Sexual Activity Factor: r = .78 (p < .001)
• Sexual Satisfaction Factor: r = .68 (p < .001)

These findings demonstrate that while the BISF-W is sensitive to genuine therapeutic or physiological shifts, its measurement baseline remains consistent in stable populations.

9. Factor Analysis

The dimensional structure of the BISF-W was evaluated using Principal Components Analysis (PCA) followed by orthogonal (Varimax) and oblique (Promax) rotations to identify underlying clinical domains.

Initial Three-Factor Solution

In the foundational validation by Rosen, Taylor, and Leiblum, PCA revealed three predominant components accounting for the majority of the common variance:

• Factor 1: Sexual Desire (Items 3, 6, 8, 14, 20) — This factor captures cognitive longing, arousal difficulty, partnered activity frequency, orgasmic capability, and dyspareunia. The diverse item composition explained the statistical split-loadings observed during initial psychometric parsing.
• Factor 2: Sexual Activity (Items 3, 4, 5, 7, 9, 10, 11, 17) — Characterized by high loadings from physical arousal, vaginal lubrication, tactile sensation, masturbation, foreplay, partner initiation, and overall sexual pleasure.
• Factor 3: Sexual Satisfaction (Items 6, 9, 10, 15, 18, 19) — Dominated by items evaluating orgasmic pleasure, satisfaction with coital frequency, and overall relationship satisfaction.

Seven-Domain Psychometric Refinement

Because the initial 3-factor structure contained complex cross-loadings that obscured specific clinical complaints (such as isolating lubrication failure from orgasmic disorder), subsequent confirmatory analyses (Mazer et al., 2000) structured the 22 items into seven conceptually coherent, clinically actionable dimensions:

1. Thought / Desire: Items 1, 2, 3 (Factor loadings > .65)
2. Arousal: Items 4, 5, 6, 7 (Factor loadings .58 to .81)
3. Frequency of Sexual Activity: Items 8, 9, 10 (Factor loadings .62 to .79)
4. Receptivity / Initiation: Items 11, 12, 13 (Factor loadings .54 to .75)
5. Pleasure / Orgasm: Items 14, 15, 16, 17 (Factor loadings .61 to .84)
6. Relationship Satisfaction: Items 18, 19 (Factor loadings .72 to .86)
7. Sexual Problems / Anxiety / Pain: Items 20, 21, 22 (Factor loadings .59 to .78)

This structural arrangement demonstrated superior construct clarity and higher fit indices (CFI > .92, RMSEA < .06) compared to the aggregated three-factor model.

10. Instrument / Measurement Tool

• Test Type: Multidimensional self-report rating scale / clinical inventory.
• Administration Format: Paper-and-pencil questionnaire or secure digital/web-based electronic survey.
• Target Population: Adult women (aged 18 and older); adaptable to premenopausal, perimenopausal, and postmenopausal cohorts.
• Item Count: 22 core items (supplemented by demographic and partner-screening items).
• Recall Period: Past month (preceding 30 days).
• Completion Time: Approximately 10 to 15 minutes.
• Response Format: Items use varying categorical and frequency/intensity scales (e.g., 5-point to 7-point scales: 0=Not at all to 4=Extremely; 0=Not at all to 6=More than once a day; 0=Extremely dissatisfied to 4=Extremely satisfied; or percentage/frequency categories).
• Primary Subscales:
  • Dimension 1: Thought/Desire (Items 1, 2, 3)
  • Dimension 2: Arousal (Items 4, 5, 6, 7)
  • Dimension 3: Frequency of Sexual Activity (Items 8, 9, 10)
  • Dimension 4: Receptivity/Initiation (Items 11, 12, 13)
  • Dimension 5: Pleasure/Orgasm (Items 14, 15, 16, 17)
  • Dimension 6: Relationship Satisfaction (Items 18, 19)
  • Dimension 7: Sexual Problems/Anxiety/Pain (Items 20, 21, 22)
• Independent Single-Item Metrics:
  • Item 16: Body image appraisal during intimacy.
  • Items 1, 2, 21, 22 (demographic screening modules): Presence of sexual partner, partner’s sexual functioning, and sexual orientation (attraction and behavior).
• Scoring Methodology:
  • Raw Summed Scoring: Items within each subscale are summed to generate domain-specific totals. Items measuring negative constructs (difficulty lubricating, difficulty reaching climax, pain, anxiety, and partner rejection) are reversed where indicated so that higher scores reflect healthier, more positive sexual functioning.
  • Composite Z-Score Transformation: In advanced clinical trials (e.g., Mazer et al., 2000), raw domain scores are converted to standardized z-scores against normative control groups, permitting the calculation of an aggregated Global Sexual Functioning Composite Index.

11. Permissions & Fee and Test Year

The Brief Index of Sexual Functioning for Women was constructed and published in 1993 by Raymond C. Rosen, Jennifer F. Taylor, and Sandra R. Leiblum. The foundational validation data were published in the Journal of Sex & Marital Therapy.

Regarding permissions, access, and intellectual property:

• Academic and Non-Commercial Research: The BISF-W is generally accessible for academic, clinical non-profit research, and independent educational inquiry. Researchers typically do not need to pay licensing fees for non-funded academic use, provided that full scientific citation and attribution are given to the original authors.
• Commercial and Funded Clinical Trials: For pharmaceutical trials, commercially sponsored studies, or integration into proprietary electronic patient-reported outcome (ePRO) platforms, formal permissions and licensing inquiries must be directed to the copyright holders or through corporate psychometric clearinghouses (historically coordinated via MAPI Research Trust / PROVIDE platform: https://eprovide.mapi-trust.org/).
• Correspondence Contact: Raymond C. Rosen, Ph.D., New England Research Institutes, Inc., 9 Galen Street, Watertown, MA 02472; E-mail: [email protected].

12. References

• Basson, R. (2000). The female sexual response: A different model. Journal of Sex & Marital Therapy, 26(1), 51–65. https://doi.org/10.1080/009262300278641
• Crowne, D. P., & Marlowe, D. (1964). The approval motive: Studies in evaluative dependence. New York: John Wiley & Sons.
• Derogatis, L. R. (1975). Derogatis Sexual Functioning Inventory (DSFI): Preliminary scoring manual. Baltimore, MD: Clinical Psychometric Research Inc.
• Howell, J. R., Reynolds, C. F., Thase, M. E., Frank, E., Jennings, J. R., Houck, P. R., Berman, S., Jacobs, E., & Kupfer, D. J. (1987). Assessment of sexual function, interest, and activity in depressed men. Journal of Affective Disorders, 13(1), 61–66. https://doi.org/10.1016/0165-0327(87)90074-9
• Kaplan, H. S. (1974). The new sex therapy: Active treatment of sexual dysfunctions. New York: Brunner/Mazel.
• Kaplan, H. S. (1979). Disorders of sexual desire and other new concepts and techniques in sex therapy. New York: Brunner/Mazel.
• Masters, W. H., & Johnson, V. E. (1966). Human sexual response. Boston: Little, Brown and Company.
• Mazer, N. A., Leiblum, S. R., & Rosen, R. C. (2000). The Brief Index of Sexual Functioning for Women (BISF-W): A new scoring algorithm and validation for analysis of laboratory and clinical trial data. Contemporary Clinical Trials, 21(5), 503.
• Reynolds, C. F., Frank, E., Thase, M. E., Houck, P. R., Jennings, J. R., Howell, J. R., Lilienfeld, S. O., & Kupfer, D. J. (1988). Assessment of sexual function in depressed, impotent, and healthy men: Factor analysis of a Brief Sexual Function Questionnaire for men. Psychiatry Research, 24(3), 231–250. https://doi.org/10.1016/0165-1781(88)90110-6
• Rosen, R. C., Taylor, J. F., Leiblum, S. R., & Bachmann, G. A. (1993). Prevalence of sexual dysfunction in women: Results of a survey study of 329 women in an outpatient gynecological clinic. Journal of Sex & Marital Therapy, 19(3), 171–188. https://doi.org/10.1080/00926239308404902
• Rosen, R., Brown, C., Heiman, J., Leiblum, S., Meston, C., Shabsigh, R., Ferguson, D., & D’Agostino, R. (2000). The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26(2), 191–208. https://doi.org/10.1080/009262300278597

13. Items of the Scale